# OXBRYTA
> **NDA216157** · New Drug Application · Sponsor: GLOBAL BLOOD THERAPS · Approved 2021-12-17
## Drug
- **FDA Application Number:** NDA216157
- **Application type:** New Drug Application
- **Brand name:** OXBRYTA
- **Generic name:** VOXELOTOR
- **Active ingredients:** VOXELOTOR
- **Dosage form:** TABLET, FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** GLOBAL BLOOD THERAPS
- **Manufacturer:** Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc.
- **First approval:** 2021-12-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216157)
---
*MORVS · CC0 1.0*